ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.49 CNY | +0.12% |
|
-3.63% | -36.69% |
| Sales 2022 | 550M 75.83M | Sales 2023 | 645M 89M | Capitalization | 5.08B 702M |
|---|---|---|---|---|---|
| Net income 2022 | 45M 6.21M | Net income 2023 | 25M 3.45M | EV / Sales 2022 | 5.25 x |
| Net cash position 2022 | 515M 71.02M | Net cash position 2023 | 194M 26.7M | EV / Sales 2023 | 7.58 x |
| P/E ratio 2022 |
65.7
x | P/E ratio 2023 |
192
x | Employees | 1,241 |
| Yield 2022 |
0.41% | Yield 2023 |
-
| Free-Float | 45.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.12% | ||
| 1 week | -3.63% | ||
| Current month | -16.02% | ||
| 1 month | -17.97% | ||
| 3 months | -24.13% | ||
| 6 months | -21.61% | ||
| Current year | -36.69% |
1 week
8.14
8.67
1 month
8.1210.49
Current year
7.0914.04
1 year
7.0915.80
3 years
6.9415.80
5 years
5.5515.80
10 years
5.5556.70
| Managers | Title | Age | Since |
|---|---|---|---|
Biao Yan
CEO | Chief Executive Officer | 42 | 20-08-27 |
Xiu Song Lin
DFI | Director of Finance/CFO | 55 | 20-12-16 |
Kai Lin
BRD | Director/Board Member | 30 | 23-05-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Tong Xu
BRD | Director/Board Member | 67 | 20-08-27 |
Wei Min Wang
BRD | Director/Board Member | 73 | 10-04-01 |
Zheng Guo Hu
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 8.49 | +0.12% | 5,163,840 |
| 24-04-23 | 8.48 | +3.54% | 8,193,605 |
| 24-04-22 | 8.19 | -4.10% | 8,772,800 |
| 24-04-19 | 8.54 | -1.16% | 5,465,800 |
| 24-04-18 | 8.64 | -1.93% | 7,213,600 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.69% | 444M | |
| +25.61% | 660B | |
| +24.29% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.57% | 219B | |
| -9.61% | 196B | |
| +6.52% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 603168 Stock
